Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|July 10, 2026
Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?Paulina J Haight, Julia C Sakach, Laura M Chambers, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2024
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology ResearchLaura Chambers, Paulina Haight, Julia Chalif, et al.
Molecular Cancer Therapeutics|September 20, 2019
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2-/- Ovarian Cancer CellsLu Liu, Shurui Cai, Chunhua Han, et al.
Gynecologic Oncology|March 11, 2006
Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancerDavid E Cohn, Sue Valmadre, Kimberly E Resnick, et al.
Gynecologic Oncology|March 30, 2024
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancerCourtney J Riedinger, David A Barrington, Christa I Nagel, et al.
American Journal of Obstetrics and Gynecology|April 23, 2005
Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysisJeffrey M Fowler, Nilsa Ramirez, David E Cohn, et al.
Gynecologic Oncology|December 7, 2002
Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?David E Cohn, Neil S Horowitz, David G Mutch, et al.
American Journal of Obstetrics and Gynecology|December 27, 2022
Postoperative venous thromboembolism risk stratification in patients with uterine cancerVincent M Wagner, Rachael N Piver, Monica D Levine, et al.
Gynecologic Oncology Reports|March 13, 2023
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancerRachael N Piver, Vincent M Wagner, Monica D Levine, et al.
Pageof 17